Overview

Evaluation of Efficacy and Safety of VX-548 for Acute Pain After a Bunionectomy

Status:
Not yet recruiting
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of VX-548 for acute pain after a bunionectomy.
Phase:
Phase 3
Details
Lead Sponsor:
Vertex Pharmaceuticals Incorporated
Treatments:
Acetaminophen